Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease by Ewelina Kulikowski, Christopher Halliday, Jan Johansson, Mike Sweeney, Kenneth Lebioda, Norman Wong, Mathias Haarhaus, Vincent Brandenburg, Srinivasan Beddhu, Marcello Tonelli, Carmine Zoccali, Kamyar Kalantar-Zadeh

Connect to this object online.

Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy by Li Fu, Sylwia Wasiak, Laura M. Tsujikawa, Brooke D. Rakai, Stephanie C. Stotz, Norman C. W. Wong, Jan O. Johansson, Michael Sweeney, Connie M. Mohan, Aneal Khan, Ewelina Kulikowski

Connect to this object online.

Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease by Sylwia Wasiak, Dean Gilham, Emily Daze, Laura M. Tsujikawa, Christopher Halliday, Stephanie C. Stotz, Brooke D. Rakai, Li Fu, Ravi Jahagirdar, Michael Sweeney, Jan O. Johansson, Norman C. W. Wong, Ewelina Kulikowski

Connect to this object online.

Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and modera... by Peter P. Toth, Gregory G. Schwartz, Stephen J. Nicholls, Aziz Khan, Michael Szarek, Henry N. Ginsberg, Jan O. Johansson, Kamyar Kalantar-Zadeh, Ewelina Kulikowski, Ken Lebioda, Norman C.W. Wong, Michael Sweeney, Kausik K. Ray

Connect to this object online.